97102 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum Purification, fragmentation
Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#602METHODS AND MATERIALS FOR MONITORING MYELOMA USING QUANTITATIVE MASS SPECTROMETRY
#603Chromatography ligand
#604Treatment of celiac disease with IgA
#605Mutated immunoglobulin-binding protein
#606Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions
#607SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
#608Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
#609Method to improve virus filtration capacity
#610CRYSTALLIZATION OF ANTI-CD20 ANTIBODIES
#611Method for Commercial Isolation of Egg Yolk IgY, Its Product, and Uses of the Product
#612Screening method for predicting susceptibility to breast cancer
#613Purification of monoclonal antibodies
#614STABILIZING POLYPEPTIDES WHICH HAVE BEEN EXPOSED TO UREA
#615Purified antibody composition
#616Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
#617THERAPEUTIC AND DIAGNOSTIC AFFINITY PURIFIED SPECIFIC POLYCLONAL ANTIBODIES
#618Immunoglobulin purification
#619Anti-estrogen and immune modulator combinations for treating breast cancer
#620ANTI-IL-9 ANTIBODY FORMULATIONS AND USES THEREOF
#621COMBINATIONS COMPRISING GEMCITABINE AND TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER
#622Breast cancer eradication program
#623Immunoglobulin constant region FC receptor binding agents
#624METHODS FOR PURIFYING ANTIBODIES USING CERAMIC HYDROXYAPATITE
#625METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#626Process for isolation and purification of a target protein free of prion protein (PrP)
#627Method for separation of immunoglobulin monomers
#628Process for the purification of Fc-containing proteins
#629Methods for purification of single domain antigen binding molecules
#630STABLE ANTIBODY COMPOSITIONS AND METHODS OF STABILIZING SAME
#631Ultra-fast chromatography
#632Purification of immunoglobulins
#633AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#634ANTIBODIES THAT BIND TO IL-18 AND METHODS OF PURIFYING THE SAME
#635Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
#636Method of isolating biomacromolecules using low pH and divalent cations
#637PROCESS FOR ENHANCING PROTEIN RECOVERY YIELDS
#638Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#639OPTIMAL PLACEMENT OF A ROBUST SOLVENT/DETERGENT PROCESS POST VIRAL ULTRAFILTRATION OF AN IMMUNE GAMMA GLOBULIN
#640Purification of acidic proteins using ceramic hydroxyapatite chromatography
#641PROCESS FOR PURIFICATION OF IMMUNOGLOBULINS USING A PSEUDOBIOAFFINITY ADSORBENT
#642SUBSTRATE FOR BIOLOGICAL FLUID TREATMENT
#643Methods and Compositions for Efficient Removal of Protein A from Binding Molecule Preparations
#644ANTI-DRUG ANTIBODY ASSAY
#645Mutant protein
#646Polypeptide producing cells
#647SKIN TAPE STRIPPING: A NON-INVASIVE DIAGNOSTIC STRATEGY FOR DERMAL EXPOSURE TO CYTOTOXIC COMPOUNDS
#648Chromatography purification of antibodies
#649Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM
#650METHOD OF SEPARATING MONOMERIC PROTEIN(S)
#651Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
#652Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
#653Purification of a bivalently active antibody using a non-chromatographic method
#654Method for purifying an IgG monomer
#655PROTEIN PURIFICATION
#656Immunoglobulin fraction and process therefor
#657PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF
#658Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
#659Pharmaceutical Compositions and Articles of Manufacture Useful in Reversal of a Clinical Episode of an Incurable Disease and Methods of Use Thereof
#660Nucleic acid capable of binding to immunoglobulin G and use thereof
#661Immunoglobulin Cleavage Fragments as Disease Indicators and Compositions for Detecting and Binding Such
#662Affinity Regions
#663ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY
#664Pharmaceutical composition of F(ab′)antibody fragments and a process for the preparation thereof
#665Reducing protein A leaching during protein A affinity chromatography
#666Method for the Purification of Antibodies
#667Isolated polypeptide binding to a sugar chain, polynucleotide encoding the polypeptide and use of the polypeptide and polynucleotide
#668Immunoglobulin fractions
#669Ion Exchange Chromatography and Purification of Antibodies
#670Antibody Binding Affinity Ligands
#671Hydrophobic Interaction Chromatography
#672STABILIZING POLYPEPTIDES WHICH HAVE BEEN EXPOSED TO UREA
#673Benzimidazole compounds and their use as chromatographic ligands
#674BREAST CANCER ERADICATION PROGRAM
#675Combinations Comprising Gemcitabine and Tyrosine Kinase Inhibitors for the Treatment of Pancreatic Cancer
#676Method of isolating antibodies by precipitation
#677METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS
#678Process for the fermentative production of antibodies
#679Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
#680Methods of purifying proteins
#681METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#682EXPRESSION OF FUNCTIONAL ANTIBODY FRAGMENTS
#683ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL
#684POLYCLONAL ANTIBODIES AGAINST FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE
#685ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL
#686Method For The Removal Of Aggregate Proteins From Recombinant Samples Using Ion Exchange Chromatography
#687Antibody purification
#688Method of antibody purification
#689Chromatography ligand
#690Process for The Manufacture of Virus Safe Immunoglobulin
#691Process for Concentration of Antibodies and Therapeutic Products Thereof
#692METHOD OF REDUCING LEACHATE FROM PROTEIN A AFFINITY MEDIA
#693Detecting molecules
#694Method of providing a purified, virus safe antibody preparation
#695Polishing steps used in multi-step protein purification processes
#696Fraction comprising guinea pig immunoglobulin e and antibody
#697Method for generating F(ab′)2 antibody fragments
#698Purification of immunoglobulins
#699Capture, Concentration And Quantitation Of Abnormal Prion Protein From Biological Fluids Using Depth Filtration
#700Method for the inactivation and removal of dengue virus from biological samples
#701Method for the treatment and prophylaxis of avian influenza infection
#702Methods of purifying anti A β antibodies
#703Methods of purifying Fc region containing proteins
#704Method of weak partitioning chromatography
#705Method of weak partitioning chromatography
#706COMPOSITIONS AND METHODS FOR PROTEIN DEAGGREGATION
#707A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide
#708Conformer-specific antibodies and method of use, thereof
#709Method for separating and concentrating biological materials using continuous-flow ultracentrifugation
#710Purification of human monoclonal antibody and human polyclonal antibody
#711Non-affinity purification of proteins
#712Protein ligands
#713Mutant protein
#714Buffered formulations for concentrating antibodies and methods of use thereof
#715Protein purification
#716Preparation of immunoglobulin
#717Methods for isolation and purification of fluorochrome-antibody conjugates
#718Method for removing DNA contaminants from a protein-containing sample
#719Stabilizing formulations
#720Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
#721Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
#722Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease
#723Method for obtaining anti-idiotype antibodies
#724Crystals of the Fc region of immunoglobulin epsilon heavy chain protein
#725Process for concentration of antibodies and therapeutic products thereof
#726Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof
#727Methods for immunoglobulin purification
#728Methods and compositions for modulating the immune system of animals
#729Antibody compositions
#730Anti-IL-9 antibody formulations
#731Expression of functional antibody fragments
#732Protein purification
#733Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
#734Methods for sterilizing preparations of monoclonal immunoglobulins
#735Three-dimensional model of a Fc region of an IgE antibody and uses thereof
#736Purification method which prevents denaturation of an antibody
#737Method of reducing leachate from protein a affinity media
#738Analyzing and typing monoclonal proteins by capillary electrophoresis and immunodisplacement
#739Mutated immunoglobulin-binding protein
#740Removal of high molecular weight aggregates using hydroxyapatite chromatography
#741Antibody stimulating il-ira production
#742Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
#743Protein purification
#744Evaluating binding affinities by force stratification and force panning
#745Method for the preparation of molecules having antibody activity
#746Reducing protein A leaching during protein A affinity chromatography
#747Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof